Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein geranylgeranyltransferase type I subunit beta is part of an enzyme complex that catalyzes the transfer of a geranylgeranyl group from geranylgeranyl diphosphate to cysteine on proteins with a C-terminal CAAX motif. This process is crucial for the proper functioning of many signal transduction proteins involved in growth and differentiation. The enzyme is heterodimeric, consisting of alpha and beta subunits, and is a key player in the post-translational modification of proteins, affecting their membrane association and biological activity.
Inhibition of geranylgeranyltransferase activity to prevent prenylation of proteins, which can disrupt signaling pathways crucial for disease progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein geranylgeranyltransferase type I subunit beta (GGTase-I beta).